Edition:
United States

Cascadian Therapeutics Inc (CASC.OQ)

CASC.OQ on NASDAQ Stock Exchange Global Select Market

3.65USD
15 Dec 2017
Change (% chg)

$-0.04 (-1.08%)
Prev Close
$3.69
Open
$3.72
Day's High
$3.74
Day's Low
$3.63
Volume
987,500
Avg. Vol
87,860
52-wk High
$5.50
52-wk Low
$3.20

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.279
Jun '17 0.00 -0.299
Mar '17 0.00 -0.298
FY 2016 Dec '16 0.00 -0.466
Sep '16 0.00 -0.522
Jun '16 0.00 -1.566
Mar '16 0.00 -0.814
FY 2015 Dec '15 0.00 -0.577
Sep '15 0.00 -0.292
Jun '15 0.00 -0.665
Mar '15 0.00 -0.484
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 4 0.00 0.00 0.00 0.00
Quarter Ending Mar-18 2 0.00 0.00 0.00 0.00
Year Ending Dec-17 4 0.00 0.00 0.00 0.00
Year Ending Dec-18 4 6.25 25.00 0.00 8.33
Earnings (per share)
Quarter Ending Dec-17 4 -0.29 -0.26 -0.31 -0.52
Quarter Ending Mar-18 2 -0.29 -0.28 -0.30 --
Year Ending Dec-17 4 -1.25 -1.14 -1.53 -2.02
Year Ending Dec-18 4 -1.10 -0.69 -1.30 -2.04
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 198.20 35.91
P/E High - Last 5 Yrs. -- 280.37 45.35
P/E Low - Last 5 Yrs. -- 93.75 24.23
Beta 2.32 0.82 0.91
Price to Sales (TTM) -- 122.78 5.95
Price to Book (MRQ) 1.48 23.45 5.68
Price to Tangible Book (MRQ) 1.71 27.39 7.29
Price to Cash Flow (TTM) -- 108.78 24.49
% Owned Institutions 81.65 5.61 1.41

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.49
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 1.99 5.25
Payout Ratio(TTM) -- 96.58 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- -5.04 6.79
Sales (TTM) vs TTM 1 Yr. Ago -- 29.98 5.62
Sales - 5 Yr. Growth Rate -- 33.48 10.24
EPS (MRQ) vs Qtr. 1 Yr. Ago 46.51 -150.15 7.85
EPS (TTM) vs TTM 1 Yr. Ago 61.44 -- --
EPS - 5 Yr. Growth Rate -- 44.93 10.94
Capital Spending - 5 Yr. Growth Rate 0.69 41.51 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.79 2.55
Current Ratio (MRQ) 11.86 5.62 3.56
LT Debt to Equity (MRQ) 0.00 16.22 13.38
Total Debt to Equity (MRQ) 0.00 18.71 19.38
Interest Coverage (TTM) -- -139.32 44.30

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 44.18 54.91
Gross Margin - 5 Yr. Avg. -- 55.78 52.46
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -215.66 15.63
Operating Margin (TTM) -- -642.63 6.56
Operating Margin - 5 Yr. Avg. -- -232.87 11.00
Pre-Tax Margin (TTM) -- -611.04 7.41
Pre-Tax Margin - 5 Yr. Avg. -- -233.04 11.41
Net Profit Margin (TTM) -- -608.78 3.64
Net Profit Margin - 5 Yr. Avg. -- -236.43 7.70
Effective Tax Rate (TTM) -- 15.53 24.28
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 22,314,532 851,801,741
Net Income/Employee (TTM) -889,193 -1,997,855 99,542,701
Receivable Turnover (TTM) -- 26.15 6.13
Inventory Turnover (TTM) -- 2.62 3.56
Asset Turnover (TTM) 0.00 0.42 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -45.01 -9.39 11.31
Return on Assets - 5 Yr. Avg. -41.06 0.28 12.28
Return on Investment (TTM) -48.47 -11.76 14.43
Return on Investment - 5 Yr. Avg. -43.38 3.42 16.07
Return on Equity (TTM) -49.46 -36.72 16.01
Return on Equity - 5 Yr. Avg. -48.33 5.75 17.27
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -54.69 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cascadian Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -8.98 -12.28 26 94
13 Week -4.45 -10.72 46 75
26 Week 6.41 -3.24 64 59
52 Week -30.21 -41.00 25 58
YTD -15.31 -29.14 40 51
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 81.67%
# of Holders: 116
Total Shares Held: 41,290,369
3 Mo. Net Change: -1,110,098
# New Positions: 17
# Closed Positions: 10
# Increased Positions: 45
# Reduced Positions: 29
# Net Buyers: 16
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.